NCT04197687 2023-12-18
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
Academic and Community Cancer Research United
Phase 2 Unknown
Clinical Trials
5 trialsNCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
NCT04158947 2020-05-12
HER2BAT
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
NCT03418558 2018-10-31
RESCUE
Fondazione del Piemonte per l'Oncologia
Phase 2 Unknown
NCT03225937 2018-10-30
HERACLES
Fondazione del Piemonte per l'Oncologia
Phase 2 Unknown